MedPath

To compare incidence of shivering with dexmedetomidine and Nalbuphine when used with bupivacaine heavy for spinal anesthesia in lower abdominal surgeries

Phase 3
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2024/08/072335
Lead Sponsor
INSTITUTE OF MEDICAL SCIENCES
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient undergoing elective surgeries under spinal anaesthesia in whom any grade of shivering was noted.

2. Those who gave informed and written consent.

3. ASA Grade I and II

Exclusion Criteria

1. Those who refused consent.

2. Age less than 20 years

3. ASA Grade III and above

4. Patient allergic to Dexmedetomidine and Nalbuphine

5. Patient with uncontrolled Hypertension, cardiovascular disease, hepatic or renal disease, bronchospastic disease.

6. Psychiatric illness

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath